{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:29:09Z","timestamp":1770812949014,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.revmed.2020.12.009","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T18:04:58Z","timestamp":1611252298000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Papillomavirus humain et lupus \u00e9ryth\u00e9mateux syst\u00e9mique"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-8199","authenticated-orcid":false,"given":"E.","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Lega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rousset-Jablonski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2020.12.009_bib0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajog.2012.09.007","article-title":"Human Papillomavirus: what every provider should know","volume":"208","author":"Erickson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0310","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/kex523","article-title":"Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention","volume":"57","author":"Kim sC","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2020.12.009_bib0315","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10067-010-1606-0","article-title":"Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review","volume":"30","author":"Santana","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0320","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection","volume":"50","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.12.009_bib0325","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","article-title":"Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus","volume":"33","author":"Lyrio","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2020.12.009_bib0330","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"issue":"CD009069","key":"10.1016\/j.revmed.2020.12.009_bib0335","first-page":"1","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2020.12.009_bib0340","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0345","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.130246","article-title":"Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis","volume":"40","author":"Heijstek","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0350","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2018.04.056","article-title":"Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus","volume":"36","author":"Mok","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0355","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0360","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.revmed.2016.01.005","article-title":"Prevention of infections in adults and adolescents with systemic lupus erythematosus: guidelines for the clinical practice based on the literature and expert opinion","volume":"37","author":"Mathian","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2020.12.009_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-016-0072-x","article-title":"HPV infection and vaccination in systemic lupus erythematosus patients: what we really should know","volume":"14","author":"Grein","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0370","unstructured":"Infections \u00e0 papillomavirus \u2014\u00a0Sant\u00e9 publique France; 2019. [site mis \u00e0 jour le 17 juin 2019; consult\u00e9 le 14\u00a0avril 2020. Disponible sur\u00a0: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/infections-a-papillomavirus]"},{"key":"10.1016\/j.revmed.2020.12.009_bib0375","unstructured":"Cancer du col de l\u2019ut\u00e9rus \u2014\u00a0Sant\u00e9 publique France; 2020. [site mis \u00e0 jour le 17 novembre 2020; consult\u00e9 le 7\u00a0novembre 2020. Disponible sur\u00a0: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/cancers\/cancer-du-col-de-l-uterus]"},{"key":"10.1016\/j.revmed.2020.12.009_bib0380","unstructured":"L\u00e9sions pr\u00e9canc\u00e9reuses \u2014\u00a0cancer du col de l\u2019ut\u00e9rus; 2020. [derni\u00e8re mise \u00e0 jour le 03\/08\/2018; consult\u00e9 le 18\u00a0novembre 2020. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Patients-et-proches\/Les-cancers\/Cancer-du-col-de-l-uterus\/Lesions-precancereuses]"},{"key":"10.1016\/j.revmed.2020.12.009_bib0385","series-title":"Le calendrier vaccinal","author":"DGS Anne","year":"2019"},{"key":"10.1016\/j.revmed.2020.12.009_bib0390","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent Human Papillomavirus vaccine: a systematic review of 10\u00a0years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0395","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ygyno.2019.03.253","article-title":"Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population","volume":"154","author":"Giuliano","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0400","doi-asserted-by":"crossref","first-page":"A462","DOI":"10.1016\/j.jval.2015.09.1198","article-title":"Loss of opportunity linked with the suboptimal coverage rate of Hpv vaccination in France","volume":"18","author":"Uhart","year":"2015","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.revmed.2020.12.009_bib0405","series-title":"Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations actualis\u00e9es","author":"HCSP","year":"2014"},{"key":"10.1016\/j.revmed.2020.12.009_bib0410","first-page":"153","article-title":"Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?","volume":"16","author":"Klumb","year":"2010","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0415","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijgo.2005.02.006","article-title":"Ominous cervical cytopathology in women with lupus","volume":"89","author":"Dhar","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.revmed.2020.12.009_bib0420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2020.12.009_bib0425","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.12.009_bib0430","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.12.009_bib0435","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/0961203313497118","article-title":"Cancer complicating systemic lupus erythematosus \u2013 a dichotomy emerging from a nested case-control study","volume":"22","author":"Dey","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2020.12.009_bib0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1590\/SO100-720320140005052","article-title":"Breast and cervical cancer in patients with systemic lupus erythematosus","volume":"36","author":"Skare","year":"2014","journal-title":"Rev Bras Ginecol E Obstet Rev Fed Bras Soc Ginecol E Obstet"},{"key":"10.1016\/j.revmed.2020.12.009_bib0445","first-page":"182","article-title":"Condyloma acuminatum by human papilloma virus infection in childhood-systemic lupus erythematosus patients","volume":"39","author":"Lube","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.revmed.2020.12.009_bib0450","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-012-2419-z","article-title":"Prevalence of Chlamydia trachomatis endocervical infection in systemic lupus erythematosus patients and evaluation of the risk for HPV-induced lesions","volume":"33","author":"CostaPinto","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2020.12.009_bib0455","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3346\/jkms.2010.25.10.1431","article-title":"Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.revmed.2020.12.009_bib0460","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.6061\/clinics\/2013(12)01","article-title":"The impact of glucocorticoids and anti-cd20\u00a0therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus","volume":"68","author":"Mendoza-Pinto","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.revmed.2020.12.009_bib0465","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/rheumatology\/keh331","article-title":"Factors associated with abnormal Pap results in systemic lupus erythematosus","volume":"43","author":"Bernatsky","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2020.12.009_bib0470","doi-asserted-by":"crossref","first-page":"E711","DOI":"10.1002\/ijc.29209","article-title":"Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study","volume":"136","author":"Dugu\u00e9","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.revmed.2020.12.009_bib0475","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0480","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/annrheumdis-2013-204993","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0485","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0961203316672928","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs","volume":"26","author":"Feldman","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2020.12.009_bib0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12\u00a0to 26\u00a0years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.revmed.2020.12.009_bib0495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"Van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.12.009_bib0500","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Hua","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2020.12.009_bib0505","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2016.06.049","article-title":"Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children","volume":"34","author":"MacIntyre","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0510","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1016\/j.vaccine.2019.07.072","article-title":"Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children","volume":"37","author":"MacIntyre","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0515","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-017-0625-z","article-title":"Safety of Human Papillomavirus vaccines: an updated review","volume":"41","author":"Phillips","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.revmed.2020.12.009_bib0520","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","article-title":"Efficacy and safety of prophylactic HPV vaccines. A cochrane review of randomized trials","volume":"17","author":"MA","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.revmed.2020.12.009_bib0525","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2017.04.001","article-title":"The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus","volume":"35","author":"Dhar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0530","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203311429556","article-title":"Systemic lupus erythematosus following HPV immunization or infection?","volume":"21","author":"Soldevilla","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2020.12.009_bib0535","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2020.12.009_bib0540","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2020.12.009_bib0545","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: a large cohort study of over 2\u00a0million young girls in France","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0550","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.medmal.2014.07.005","article-title":"HPV vaccination is still difficult to implement","volume":"44","author":"Gaudelus","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2020.12.009_bib0555","first-page":"443","article-title":"Regression of vaccine coverage HPV: a French exception","volume":"45","author":"H\u00e9quet","year":"2017","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0560","doi-asserted-by":"crossref","first-page":"e0117620","DOI":"10.1371\/journal.pone.0117620","article-title":"Human Papillomavirus vaccine uptake among individuals with systemic inflammatory diseases","volume":"10","author":"Feldman","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.revmed.2020.12.009_bib0565","first-page":"348","article-title":"Lack of uptake of prophylactic Human Papilloma virus vaccine among women with systemic lupus erythematosus seen at a regional medical center","volume":"8","author":"Dhar","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.revmed.2020.12.009_bib0570","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpag.2016.08.005","article-title":"Human papillomavirus vaccination of adolescents with chronic medical conditions: a National Survey of Pediatric Subspecialists","volume":"30","author":"Hofstetter","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.revmed.2020.12.009_bib0575","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/rheumatology\/key120","article-title":"Vaccination coverage in systemic lupus erythematosus \u2013 a cross-sectional analysis of the German long-term study (LuLa cohort)","volume":"57","author":"Chehab","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2020.12.009_bib0580","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1016\/j.vaccine.2017.07.042","article-title":"Chronically ill adolescents are also incompletely vaccinated: a cross-sectional study in France","volume":"35","author":"Gras-Le Guen","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.revmed.2020.12.009_bib0585","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/rheumatology\/kes175","article-title":"Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre","volume":"51","author":"Morin","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2020.12.009_bib0590","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14760584.2014.930346","article-title":"Should we target patients with autoimmune diseases for HPV vaccine uptake?","volume":"13","author":"Feldman","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.revmed.2020.12.009_bib0595","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/rheumatology\/keu531","article-title":"Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients","volume":"54","author":"Hua","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2020.12.009_bib0300","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.autrev.2018.04.006","article-title":"Recommendations and barriers to vaccination in systemic lupus erythematosus","volume":"17","author":"Garg","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320308626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320308626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:43:59Z","timestamp":1759337039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320308626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0248866320308626"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.12.009","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillomavirus humain et lupus \u00e9ryth\u00e9mateux syst\u00e9mique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}